Steven Zelenkofske's Net Worth
$1.75 Million
Who is Steven Zelenkofske?
Steven Zelenkofske has an estimated net worth of $1.75 Million. This is based on reported shares across multiple companies, which include uniQure N.V., Cadrenal Therapeutics, Inc., Regado Biosciences Inc, and ACHILLION PHARMACEUTICALS INC.
SEC CIK
Steven Zelenkofske's CIK is 0001578333
Past Insider Trading and Trends
2018 was Steven Zelenkofske's most active year for acquiring shares with 3 total transactions. Steven Zelenkofske's most active month to acquire stocks was the month of December. 2020 was Steven Zelenkofske's most active year for disposing of shares, totalling 2 transactions. Steven Zelenkofske's most active month to dispose stocks was the month of December. 2018 saw Steven Zelenkofske paying a total of $0.00 for 530,751 shares, this is the most they've acquired in one year. In 2018 Steven Zelenkofske cashed out on 23,929 shares for a total of $888,723.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
uniQure N.V. (QURE) Snapshot price: $5.42
Chief Medical OfficerSteven Zelenkofske owns 159,458 units of Ordinary Shares which is worth $864,262.36. In the year 2017 Steven Zelenkofske filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.05% | -23.93K |
$37.14 | -$888,723.06 | 159.46K |
Jun 6
| |||
Form 4
| +4.79% | 8.39K |
—
|
—
| 183.39K |
Jan 26
| |||
Form 4
|
∞
| 175K |
—
|
—
| 175K |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cadrenal Therapeutics, Inc. (CVKD) Snapshot price: $7.81
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Regado Biosciences Inc No price found
SVP & Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACHILLION PHARMACEUTICALS INC No price found
EVP, Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |